Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Volume 1869, Issue 8, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.bbamcr.2022.119266
Keywords
Proteomics; Cancer; Immunity; Single-cell; T cells; Immunotherapy
Categories
Funding
- National Science Centre, Poland [1: 2018/30/Q/NZ6/]
- Academy of Finland [325965]
- Academy of Finland (AKA) [325965, 325965] Funding Source: Academy of Finland (AKA)
Ask authors/readers for more resources
This review discusses the application of proteomics studies in characterizing immune responses and tumor immune microenvironment heterogeneity in cancer. Proteomics studies have gained considerable attention in recent years for decoding immune responses, and they are proven to be more accurate in reflecting cell state compared to genomics or transcriptomics studies.
Despite the dynamic development of cancer research, annually millions of people die of cancer. The human immune system is the major 'guard' against tumor development. Unfortunately, cancer cells have the ability to evade the immune system and continue to grow. The proper understanding of the intricate immune response in tumorigenesis remains the holy grail of cancer immunology and designing effective immunotherapy. To decode the immune responses in cancer, in recent years, proteomics studies have received considerable attention. Proteomics studies focus on the detection and quantification of proteins, which are the effectors of biological functions, and as such, are proven to reflect the cell state more accurately, in comparison to genomic or transcriptomic studies. In this review, we discuss the proteomics studies applied to characterize the immune responses in cancer and tumor immune microenvironment heterogeneity. Further, we describe emerging single-cell proteomics approaches that have the potential to be applied in cancer immunity studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available